Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Overcoming Obstacles in AAV Viral Vector Manufacturing
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
View All Featured ArticlesHeadline News
FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy
Roche receives CE Mark for compact cobas smart e immunoanalyser
Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Validation Of Endotoxin Testing For CAR T-cell Manufacturing Quality Control & Benefits of Cartridge Technology
Presented by Dr. Zlatibor Velickovic PhD Production Manager | Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital Sydney, Australia, ISCT Regional Vice-President Elect, Australia & New Zealand and Alan Hoffmeister Senior Global Technology & Market Development Manager, Charles River Laboratories
28th October 2021
Establishing Early Development Strategies For Therapeutics Proteins
Presented by Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Lead Early Phase Biologics at Novartis and Bernardo Cordovez, PhD, Chief Science Officer & Founder, Halo Labs
21st October 2020
Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay
Presented by Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX
28th June 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Amsphere TM A3
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
